April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
Amazon: The Margin Train Is Gaining Speed
Amazon Web Services Expands Bedrock GenAI Service
Why Microsoft Stands Out As A Pre-Earnings Buy
Wall Street Lunch: Big Tech Bearishness?
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Aerie Pharmaceuticals (AERI) stock forecast for 2025
Updated: April 22, 2024 (14:01)
Sector: HealthcareThe share price of Aerie Pharmaceuticals, Inc. (AERI) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Aerie Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Aerie Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Aerie Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aerie Pharmaceuticals stock price in 2025. How much will one Aerie Pharmaceuticals share be worth in 2025? Is it worth taking profit / loss on AERI stock now or waiting? What are analysts' forecasts for Aerie Pharmaceuticals stock?
We forecast Aerie Pharmaceuticals stock performance using neural networks based on historical data on AERI stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Aerie Pharmaceuticals, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Aerie Pharmaceuticals analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Aerie Pharmaceuticals, Inc. stock
The chart below shows the historical price of Aerie Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AERI stock price can be found in the table below.
Aerie Pharmaceuticals Inc. (Nasdaq: AERI) is a publicly traded, clinical stage pharmaceutical company dedicated to discovering, developing and commercializing first-class treatments for patients with glaucoma and other eye conditions.
Aerie Pharmaceuticals (AERI) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 19.90 | 17.71 | 20.78 | 14.75 % |
| Feb | 23.09 | 21.06 | 24.47 | 13.96 % |
| Mar | 22.07 | 20.44 | 25.03 | 18.34 % |
| Apr | 17.79 | 15.80 | 20.60 | 23.32 % |
| May | 19.32 | 16.81 | 22.41 | 25.00 % |
| Jun | 18.74 | 16.34 | 21.18 | 22.83 % |
| Jul | 19.38 | 17.56 | 21.31 | 17.64 % |
| Aug | 17.63 | 15.90 | 19.64 | 19.03 % |
| Sep | 16.65 | 14.25 | 17.88 | 20.30 % |
| Oct | 18.24 | 15.73 | 20.51 | 23.31 % |
| Nov | 18.72 | 17.89 | 21.41 | 16.43 % |
| Dec | 17.44 | 15.67 | 18.46 | 15.12 % |
Aerie Pharmaceuticals information and performance
N/A
Market capitalization of the Aerie Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AERI shares in the company outstanding by the market price of one share.
EBITDA of Aerie Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aerie Pharmaceuticals price target for 2025 by month
Target values for the price of one Aerie Pharmaceuticals share for Jan 2025.
In Jan, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.751% volatility is expected.
Pessimistic target level: 17.71
Optimistic target level: 20.78
Target values for the price of one Aerie Pharmaceuticals share for Feb 2025.
In Feb, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 13.962% volatility is expected.
Pessimistic target level: 21.06
Optimistic target level: 24.47
Target values for the price of one Aerie Pharmaceuticals share for Mar 2025.
In Mar, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 18.342% volatility is expected.
Pessimistic target level: 20.44
Optimistic target level: 25.03
Target values for the price of one Aerie Pharmaceuticals share for Apr 2025.
In Apr, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 23.316% volatility is expected.
Pessimistic target level: 15.80
Optimistic target level: 20.60
Target values for the price of one Aerie Pharmaceuticals share for May 2025.
In May, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 25.000% volatility is expected.
Pessimistic target level: 16.81
Optimistic target level: 22.41
Target values for the price of one Aerie Pharmaceuticals share for Jun 2025.
In Jun, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 22.832% volatility is expected.
Pessimistic target level: 16.34
Optimistic target level: 21.18
Target values for the price of one Aerie Pharmaceuticals share for Jul 2025.
In Jul, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 17.636% volatility is expected.
Pessimistic target level: 17.56
Optimistic target level: 21.31
Target values for the price of one Aerie Pharmaceuticals share for Aug 2025.
In Aug, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 19.030% volatility is expected.
Pessimistic target level: 15.90
Optimistic target level: 19.64
Target values for the price of one Aerie Pharmaceuticals share for Sep 2025.
In Sep, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 20.298% volatility is expected.
Pessimistic target level: 14.25
Optimistic target level: 17.88
Target values for the price of one Aerie Pharmaceuticals share for Oct 2025.
In Oct, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 23.310% volatility is expected.
Pessimistic target level: 15.73
Optimistic target level: 20.51
Target values for the price of one Aerie Pharmaceuticals share for Nov 2025.
In Nov, the Positive dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.433% volatility is expected.
Pessimistic target level: 17.89
Optimistic target level: 21.41
Target values for the price of one Aerie Pharmaceuticals share for Dec 2025.
In Dec, the Negative dynamics for Aerie Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 15.123% volatility is expected.
Pessimistic target level: 15.67
Optimistic target level: 18.46
Related stocks from Healthcare sector
